Atezolizumab Biosimilar, Human IgG4 S228P Mutant, Endotoxin 0.05 EU/mg | C024P.4S.05
Atezolizumab Biosimilar, Human IgG4 S228P Mutant, Endotoxin 0.05 EU/mg. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks...
